Metformin as an adjuvant in breast cancer treatment
Breast cancer is one of the most common malignancies in females. It is an etiologically complex disease driven by a multitude of cellular pathways. The proliferation and spread of breast cancer is intimately linked to cellular glucose metabolism, given that glucose is an essential cellular metabolic...
Main Authors: | Mohsin HK Roshan, Yan K Shing, Nikolai P Pace |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-07-01
|
Series: | SAGE Open Medicine |
Online Access: | https://doi.org/10.1177/2050312119865114 |
Similar Items
-
Metformin as an adjuvant option for systemic treatment of breast cancer
by: D.I. Avierin, et al.
Published: (2023-12-01) -
Efficacy of Metformin as Adjuvant Therapy in Metastatic Breast Cancer Treatment
by: Nourhan M. Essa, et al.
Published: (2022-09-01) -
Adjuvant treatment for breast cancer
by: Flatley, M, et al.
Published: (2019) -
Metformin as an archetype immuno-metabolic adjuvant for cancer immunotherapy
by: Sara Verdura, et al.
Published: (2019-10-01) -
Exploring the Mechanism of Adjuvant Treatment of Glioblastoma Using Temozolomide and Metformin
by: Shao-Wei Feng, et al.
Published: (2022-07-01)